Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre‐diabetes and diabetes. The KORA Myocardial Infarction Registry
- 1 July 2009
- journal article
- Published by Wiley in European journal of pain
- Vol. 13 (6) , 582-587
- https://doi.org/10.1016/j.ejpain.2008.07.007
Abstract
The lowest glycemic threshold for and the risk factors associated with neuropathic pain have not been established. The aim of this study was to determine the prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), normal glucose tolerance (NGT). Subjects aged 25–74 years with diabetes (n=214) and controls matched for age and sex (n=212) from the population‐based KORA (Cooperative Health Research in the Region of Augsburg) Myocardial Infarction Registry were assessed for neuropathic pain by the Michigan Neuropathy Screening Instrument using its pain‐relevant questions and an examination score cutpoint >2. An oral glucose tolerance test was performed in the controls. Among the controls, 61 (28.8%) had IGT (either isolated or combined with IFG), 70 (33.0%) had isolated IFG, and 81 had NGT. The prevalence of neuropathic pain was 21.0% in the diabetic subjects, 14.8% in those with IGT, 5.7% in those with IFG, and 3.7% in those with NGT (overall pn=426), age, waist circumference, peripheral arterial disease (PAD), and diabetes were independent factors significantly associated with neuropathic pain, while in the diabetic group it was waist circumference, physical activity, and PAD (all p<0.05). In conclusion, the prevalence of neuropathic pain is relatively high among survivors of myocardial infarction with diabetes and IGT compared to those with isolated IFG and NGT. Associated cardiovascular risk factors including abdominal obesity and low physical activity may constitute targets to prevent neuropathic pain in this population.Keywords
This publication has 39 references indexed in Scilit:
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population‐based studyMuscle & Nerve, 2007
- Established diabetic neuropathy seems irreversible despite improvements in metabolic and vascular risk markers—a retrospective case–control study in a hospital patient cohortDiabetic Medicine, 2006
- Peripheral Insensate Neuropathy—A Tall Problem for US Adults?American Journal of Epidemiology, 2006
- Knowledge about Diabetes and Participation in Diabetes Training Courses: The Need for Improving Health Care for Diabetes Patients with Low SESExperimental and Clinical Endocrinology & Diabetes, 2006
- Therapy Insight: neurological complications of prediabetesNature Clinical Practice Neurology, 2006
- Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathyClinical Neurology and Neurosurgery, 2005
- A controlled investigation of the cause of chronic idiopathic axonal polyneuropathyBrain, 2004
- The Prevalence of Diabetic Distal Sensory Neuropathy in an English CommunityDiabetic Medicine, 1992